α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice
Authors
Keywords
-
Journal
Pharmaceutics
Volume 13, Issue 6, Pages 771
Publisher
MDPI AG
Online
2021-05-24
DOI
10.3390/pharmaceutics13060771
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives
- (2021) Zimei Wu et al. PHARMACEUTICAL RESEARCH
- Fabry Disease: The Current Treatment Landscape
- (2021) Malte Lenders et al. DRUGS
- Developments in the treatment of Fabry disease
- (2020) Sanne J. Veen et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA
- (2020) Itziar Gómez-Aguado et al. MOLECULES
- Methotrexate-Loaded Solid Lipid Nanoparticles: Protein Functionalization to Improve Brain Biodistribution
- (2019) Elisabetta Muntoni et al. Pharmaceutics
- Improved Efficacy in a Fabry Disease Model Using a Systemic mRNA Liver Depot System as Compared to Enzyme Replacement Therapy
- (2019) Frank DeRosa et al. MOLECULAR THERAPY
- How mRNA therapeutics are entering the monoclonal antibody field
- (2019) Lien Van Hoecke et al. Journal of Translational Medicine
- Migalastat: A Review in Fabry Disease
- (2019) Emma H. McCafferty et al. DRUGS
- Systemic mRNA Therapy for the Treatment of Fabry Disease: Preclinical Studies in Wild-Type Mice, Fabry Mouse Model, and Wild-Type Non-human Primates
- (2019) Xuling Zhu et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Lipid-Based DNA Therapeutics – Hallmarks of Non-Viral Gene Delivery
- (2019) Jonas Buck et al. ACS Nano
- Clinical translation of gene medicine
- (2019) Fazhan Wang et al. JOURNAL OF GENE MEDICINE
- Progress in the understanding and treatment of Fabry disease
- (2019) James J. Miller et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Fabry disease genotype, phenotype, and migalastat amenability: Insights from a national cohort
- (2019) Albina Nowak et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Sugar ligand-mediated drug delivery
- (2019) Fang Chen et al. Future Medicinal Chemistry
- The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
- (2018) Wei-Wei Zhang et al. HUMAN GENE THERAPY
- Applications of lipid nanoparticles in gene therapy
- (2016) Ana del Pozo-Rodríguez et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Vaginal gene therapy
- (2015) Alicia Rodríguez-Gascón et al. ADVANCED DRUG DELIVERY REVIEWS
- Solid Lipid Nanoparticles as Non-Viral Vectors for Gene Transfection in a Cell Model of Fabry Disease
- (2015) A. P. Ruiz de Garibay et al. Journal of Biomedical Nanotechnology
- Solid lipid nanoparticle-based vectors intended for the treatment of X-linked juvenile retinoschisis by gene therapy: In vivo approaches in Rs1h -deficient mouse model
- (2015) P.S. Apaolaza et al. JOURNAL OF CONTROLLED RELEASE
- Solid lipid nanoparticles for drug delivery
- (2015) M. Harms et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- New gene delivery system based on oligochitosan and solid lipid nanoparticles: ‘In vitro’ and ‘in vivo’ evaluation
- (2013) Diego Delgado et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Biodistribution of Nanostructured Lipid Carriers (NLCs) after intravenous administration to rats: Influence of technological factors
- (2013) A. Beloqui et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Dextran–protamine–solid lipid nanoparticles as a non-viral vector for gene therapy: In vitro characterization and in vivo transfection after intravenous administration to mice
- (2012) Diego Delgado et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Metabolic Adaptive ALT Isoenzyme Response in Livers of C57/BL6 Mice Treated with Dexamethasone
- (2012) William J. Reagan et al. TOXICOLOGIC PATHOLOGY
- Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy
- (2012) Aritz Perez Ruiz de Garibay et al. Drug Design Development and Therapy
- Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective
- (2011) S.M. Moghimi et al. Annual Review of Pharmacology and Toxicology
- Overcoming in vivo barriers to targeted nanodelivery
- (2011) Adrian Chrastina et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Solid lipid nanoparticles as potential tools for gene therapy: In vivo protein expression after intravenous administration
- (2009) Ana del Pozo-Rodríguez et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now